Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan J Melenhorst

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of the American Academy of Dermatology|October 18, 2016
Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapyCourtney B Rubin, Rosalie Elenitsas, Laura Taylor, et al.
Blood|September 25, 2009
The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donorPhillip Scheinberg, Jan J Melenhorst, Jason M Brenchley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 1, 2014
Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cellsJan J Melenhorst, Paul Castillo, Patrick J Hanley, et al.
Annals of Neurology|September 5, 2018
Neurotoxicity after CTL019 in a pediatric and young adult cohortJacqueline S Gofshteyn, Pamela A Shaw, David T Teachey, et al.
The New England Journal of Medicine|December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasStephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.
Science Translational Medicine|May 1, 2015
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivoPatrick J Hanley, Jan J Melenhorst, Sarah Nikiforow, et al.
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
Blood|May 12, 2016
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of the American Academy of Dermatology|October 18, 2016
Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapyCourtney B Rubin, Rosalie Elenitsas, Laura Taylor, et al.
Blood|September 25, 2009
The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donorPhillip Scheinberg, Jan J Melenhorst, Jason M Brenchley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 1, 2014
Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cellsJan J Melenhorst, Paul Castillo, Patrick J Hanley, et al.
Annals of Neurology|September 5, 2018
Neurotoxicity after CTL019 in a pediatric and young adult cohortJacqueline S Gofshteyn, Pamela A Shaw, David T Teachey, et al.
The New England Journal of Medicine|December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasStephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.
Science Translational Medicine|May 1, 2015
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivoPatrick J Hanley, Jan J Melenhorst, Sarah Nikiforow, et al.
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
Blood|May 12, 2016
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, et al.
Pageof 3